These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8527420)

  • 21. Seventeenth annual INS meeting. International Neuropsychological Society. February 8-11, 1989, Vancouver, B.C., Canada. Abstracts.
    J Clin Exp Neuropsychol; 1989 Jan; 11(1):17-109. PubMed ID: 2918064
    [No Abstract]   [Full Text] [Related]  

  • 22. Abstracts of the 4th European College of Neuropsychopharmacology Workshop: Neuropsychopharmacology of addiction. Nice, France, March 15-17, 2003.
    Eur Neuropsychopharmacol; 2003 Mar; 13 Suppl 1():S1-35. PubMed ID: 12696567
    [No Abstract]   [Full Text] [Related]  

  • 23. About the American College of Neuropsychopharmacology.
    Ray OS
    Acad Psychiatry; 2007; 31(2):122-4. PubMed ID: 17344449
    [No Abstract]   [Full Text] [Related]  

  • 24. [Japanese Society of Biological Psychiatry--biological studies of affective disturbances--recent progress].
    Higuchi T
    Seishin Shinkeigaku Zasshi; 1999; 101(10):808-12. PubMed ID: 10638261
    [No Abstract]   [Full Text] [Related]  

  • 25. Proceedings of the ECNP constituent meeting. European College of Neuropsychopharmacology. Brussels, May 1987.
    Pharmacopsychiatry; 1988 Jan; 21(1):1-68. PubMed ID: 3362960
    [No Abstract]   [Full Text] [Related]  

  • 26. [29th annual meeting of the Japanese Society of Neuropsychopharmacology. Hiroshima, Japan. September 14-15, 2000. Abstracts].
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Dec; 19(6):281-452. PubMed ID: 10810607
    [No Abstract]   [Full Text] [Related]  

  • 27. [Proceeding of 26th annual meeting of the Japanese Society of Neuropsychopharmacology. Tokyo, Japan. October 24-25, 1996. Abstracts].
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Dec; 16(6):217-388. PubMed ID: 9055311
    [No Abstract]   [Full Text] [Related]  

  • 28. [Proceedings of 31st annual meeting of the Japanese Society of Neuropsychopharmacology. Hiroshima, Japan. October 4-5, 2001. Abstracts].
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Dec; 21(6):193-390. PubMed ID: 11917884
    [No Abstract]   [Full Text] [Related]  

  • 29. [Proceeding of 33rd annual meeting of the Japanese Society of Neuropsychopharmacology. Nara, Japan. October 9-10, 2003. Abstracts].
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Dec; 23(6):223-359. PubMed ID: 14750504
    [No Abstract]   [Full Text] [Related]  

  • 30. [Proceeding of 40th annual meeting of the Japanese Society of Neuropsychopharmacology. Sendai, Japan. September 15-17, 2010. Abstracts].
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010; Suppl():33-210. PubMed ID: 21520679
    [No Abstract]   [Full Text] [Related]  

  • 31. [Proceeding of 34th annual meeting of the Japanese Society of Neuropsychopharmacology. Tokyo, Japan. July 21-23, 2004. Abstracts].
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Dec; 24(6):321-436. PubMed ID: 15706693
    [No Abstract]   [Full Text] [Related]  

  • 32. [Proceeding of 41st annual meeting of the Japanese Society of Neuropsychopharmacology. Tokyo, Japan. October 27-29, 2011. Abstracts].
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Oct; Suppl Godo Nenkai():73-241. PubMed ID: 22238827
    [No Abstract]   [Full Text] [Related]  

  • 33. [Proceedings of 28th annual meeting of the Japanese Society of Neuropsychopharmacology. Tokyo, Japan. October 21-23, 1998. Abstracts].
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Dec; 18(6):241-405. PubMed ID: 10197327
    [No Abstract]   [Full Text] [Related]  

  • 34. [Proceeding of 27th annual meeting of the Japanese Society of Neuropsychopharmacology. Kagoshima, Japan. October 21-22, 1997. Abstracts].
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Dec; 17(6):217-388. PubMed ID: 9499912
    [No Abstract]   [Full Text] [Related]  

  • 35. [Proceeding of 35th annual meeting of the Japanese Society of Neuropsychopharmacology. Osaka, Japan. July 6-8, 2005. Abstracts].
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Dec; 25(6):259-387. PubMed ID: 16470957
    [No Abstract]   [Full Text] [Related]  

  • 36. [Proceedings of the 25th annual meeting of the Japanese Society of Neuropsychopharmacology. Fukuoka City. Japan. October 16-17, 1995. Abstracts].
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Dec; 15(6):455-636. PubMed ID: 8608426
    [No Abstract]   [Full Text] [Related]  

  • 37. [Proceeding of 44th annual meeting of the Japanese Society of Neuropsychopharmacology. Nagoya, Japan. November 20-22, 2014. Abstracts].
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2014 Nov; Suppl Godo Nenkai():85-221. PubMed ID: 26437468
    [No Abstract]   [Full Text] [Related]  

  • 38. Perspectives in Canadian neuro-psychopharmacology. Proceedings of the 10th annual meeting of the Canadian College of Neuro-psychopharmacology. Ottawa, May 19-23, 1987.
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(2-3):117-362. PubMed ID: 3387584
    [No Abstract]   [Full Text] [Related]  

  • 39. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Teaching on addiction issues lacking in medical school, specialists told.
    Robb N
    CMAJ; 1998 Mar; 158(5):640-1. PubMed ID: 9526484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.